Drug company chairman calls for change to ‘appalling’ rules on NHS drug prices
Copy link
AstraZeneca threatens to stop investing in Britain
Drug company chairman calls for change to ‘appalling’ rules on NHS drug prices
966 words~4 min read
Drug company chairman calls for change to ‘appalling’ rules on NHS drug prices
Drug company chairman calls for change to ‘appalling’ rules on NHS drug prices
Copy link
Drug companies increasingly frustrated with the Government over surging NHS clawbacks
The UK’s uncompetitive policies have led to years of chronic underinvestment
The US president has told GSK and AstraZeneca to ‘negotiate harder with foreign freeloading nations’
Eli Lilly calls on Britain’s health service to pay higher prices for medicines
AstraZeneca chief executive Pascal Soriot has thanked the Government ‘for their efforts to improve access for patients’
Drugmaker had stalled large-scale projects in England but has now pledged investment at two sites, announced by Keir Starmer
